Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VIE

Viela Bio (VIE) Stock Price, News & Analysis

Viela Bio logo

About Viela Bio Stock (NASDAQ:VIE)

Advanced Chart

Key Stats

Today's Range
$53.01
$53.01
50-Day Range
$52.92
$53.20
52-Week Range
$25.02
$65.00
Volume
N/A
Average Volume
1.07 million shs
Market Capitalization
$2.91 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VIE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viela Bio and its competitors with MarketBeat's FREE daily newsletter.

VIE Stock News Headlines

RGNX-Aktie erreicht 52-Wochen-Tief bei 9,28 US-Dollar
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Regenxbio Names Mitchell Chan CFO
2024 Fire Awards: Meet this year's Ablaze honorees
See More Headlines

VIE Stock Analysis - Frequently Asked Questions

Viela Bio, Inc. (NASDAQ:VIE) issued its earnings results on Sunday, February, 28th. The company reported ($0.60) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.70) by $0.10. The company earned $9.34 million during the quarter, compared to analysts' expectations of $5.10 million.

Viela Bio (VIE) raised $150 million in an initial public offering on Thursday, October 3rd 2019. The company issued 7,500,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, Morgan Stanley and Cowen acted as the underwriters for the IPO and Guggenheim Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viela Bio investors own include Enovix (ENVX), Rambus (RMBS), COMPASS Pathways (CMPS), Toast (TOST), Ginkgo Bioworks (DNA), Globant (GLOB) and Saia (SAIA).

Company Calendar

Last Earnings
2/28/2021
Today
7/08/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VIE
CIK
N/A
Fax
N/A
Employees
166
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$86.43 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$50 million
Price / Cash Flow
N/A
Book Value
$7.14 per share
Price / Book
7.42

Miscellaneous

Free Float
N/A
Market Cap
$2.91 billion
Optionable
Not Optionable
Beta
0.43
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:VIE) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners